The break point cluster–Abelson tyrosine kinase (BCR–ABL) oncogene is formed in patients with chronic myeloid leukemia and acute lymphoblastic leukemia by fusing the BCR gene on chromosome 22 and the ABL tyrosine kinase on chromosome 9. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.